Clinical Trials in Tennessee

Showing 4721-4740 of 20,239 trials

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

NCT06213831

This study is being conducted to determine the safety and tolerability of ruxolitinib 1.5% cream under maximal use conditions in participants with Prurigo Nodularis (PN).

Prurigo Nodularis

Incyte Corporation23 participantsStarted Feb 2024

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Fountain Valley, California, United States +17 more locations

Active Not RecruitingPhase 329 miles

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

NCT05239728

The purpose of this study is to assess the efficacy and safety of oral belzutifan (MK-6482) plus intravenous (IV) pembrolizumab (MK-3475) compared to placebo plus pembrolizumab, in the adjuvant treatment of Clear Cell Renal Cell Carcinoma (ccRCC) post nephrectomy. The primary study hypothesis is that belzutifan plus pembrolizumab is superior to placebo plus pembrolizumab with respect to disease-free survival (DFS).

Carcinoma, Renal Cell

Merck Sharp & Dohme LLC1,800 participantsStarted Mar 2022

Phoenix, Arizona, United States • Duarte, California, United States • La Jolla, California, United States +282 more locations

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

Find Trials by Condition in Tennessee

Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]

The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

Expanded Access of Sotorasib

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients

A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

Evaluation of Non-Invasive Tests for Metabolic Liver Disease

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Scaling Up Maternal Mental Healthcare by Increasing Access to Treatment (SUMMIT)

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours

Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma

Topical ENS-002 for Atopic Dermatitis in Adults